Bial - Portela & CA S.A. et al v Alkem Laboratories Limited et al
| Sunovion Pharmaceuticals Inc., Bial - Holding, S.A. and Bial - Portela & CA S.A. |
| S&B Pharma, Inc. and Alkem Laboratories Limited |
| 1:2021cv00186 |
| February 10, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 26, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions for Patent No. 10,912,781 filed by Bial - Holding, S.A., Bial - Portela & CA S.A..(Balick, Steven) |
| Filing 11 ANSWER to #6 Answer to Complaint,, Counterclaim, by Bial - Holding, S.A., Bial - Portela & CA S.A..(Balick, Steven) |
| Pro Hac Vice Attorneys James B. Monroe and Meredith H. Boerschlein for Bial - Holding, S.A. and Bial - Portela & CA S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-00186-CFC, 1:21-cv-00187-CFC, 1:21-cv-00188-CFC, 1:21-cv-00189-CFC, 1:21-cv-00190-CFC. (kmd) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Jennifer H. Roscetti, Charles T. Collins-Chase, Lauren J. Dowty, Meredith H. Boerschlein, and Ryan V. McDonnell - filed by Bial - Holding, S.A., Bial - Portela & CA S.A.. (Balick, Steven) |
SO ORDERED, re (13 in 1:21-cv-00188-CFC, 11 in 1:21-cv-00189-CFC, 13 in 1:21-cv-00187-CFC, 10 in 1:21-cv-00186-CFC, 14 in 1:21-cv-00190-CFC) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Jennifer H. Roscetti, Charles T. Collins-Chase, Lauren J. Dowty, Meredith H. Boerschlein, and Ryan V. McDonnell filed by Bial - Portela & CA S.A., Bial - Holding, S.A. Signed by Judge Colm F. Connolly on 3/16/2021. Associated Cases: 1:21-cv-00186-CFC, 1:21-cv-00187-CFC, 1:21-cv-00188-CFC, 1:21-cv-00189-CFC, 1:21-cv-00190-CFC(fms)
|
|
Filing 9
SO ORDERED, re (7 in 1:21-cv-00189-CFC, 9 in 1:21-cv-00187-CFC, 7 in 1:21-cv-00186-CFC, 9 in 1:21-cv-00190-CFC, 9 in 1:21-cv-00188-CFC) STIPULATION Seeking Adoption of the Original and Once-Daily Scheduling Order in the New Cases Asserting the '781 Patent, by Bial - Holding, S.A., Bial - Portela & CA S.A. Signed by Judge Colm F. Connolly on 3/11/2021. Associated Cases: 1:21-cv-00186-CFC, 1:21-cv-00187-CFC, 1:21-cv-00188-CFC, 1:21-cv-00189-CFC, 1:21-cv-00190-CFC(nmf)
|
| Filing 8 NOTICE OF SERVICE of Plaintiffs' Second Amended Fed. R. Civ. P. 26(a)(1) Initial Disclosures to Alkem Defendants and Plaintiffs' Second Amended Initial Disclosures to Alkem Defendants Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Bial - Holding, S.A., Bial - Portela & CA S.A., BIAL - PORTELA & CA. S.A..(Mayo, Andrew) |
| Filing 7 STIPULATION Seeking Adoption of the Original and Once-Daily Scheduling Order in the New Cases Asserting the '781 Patent, by Bial - Holding, S.A., Bial - Portela & CA S.A.. (Balick, Steven) |
| Filing 6 ANSWER to #1 Complaint, Defendants Alkem Laboratories Limited and S&B Pharma, Inc.'s Answer, Affirmative Defenses, and, COUNTERCLAIM against Bial - Holding, S.A., Bial - Portela & CA S.A., Sunovion Pharmaceuticals Inc. by Alkem Laboratories Limited, S&B Pharma, Inc..(Schladweiler, Benjamin) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sumitomo Dainippon Pharma Co., Ltd. for Sunovion Pharmaceuticals Inc.; Corporate Parent Bial - Holding, S.A. for Bial - Portela & CA S.A. filed by Bial - Holding, S.A., Bial - Portela & CA S.A., Sunovion Pharmaceuticals Inc.. (Balick, Steven) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-00186-CFC, 1:21-cv-00187-CFC, 1:21-cv-00188-CFC, 1:21-cv-00189-CFC, 1:21-cv-00190-CFC (rjb) |
| No Summons Issued. (amf) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 10/23/2028.Thirty Month Stay Deadline: 5/8/2021. (amf) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,912,781. (amf) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Alkem Laboratories Limited, S&B Pharma, Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 402, receipt number ADEDC-3517999.) - filed by Bial - Holding, S.A., Sunovion Pharmaceuticals Inc., Bial - Portela & CA S.A. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(amf) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
